FDA Inspection
Life Line Stem Cell, Inc.Life Line Stem Cell, Inc. – FDA Inspection, Jul 31, 2018
Record Details
This FDA Inspection record concerns Life Line Stem Cell, Inc., with an inspection on July 31, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · c1bfca35-8333-4d72-8c6f-c0f0e8f6d42b
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1066109
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Life Line Stem Cell, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| January 16, 2026 | Not classified | Detroit District Office | Human Cellular, Tissue, and Gene Therapies |
| September 12, 2024 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 7, 2019 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 27, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 6, 2014 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Life Line Stem Cell, Inc.
- FDA Inspection 1286086 - 2026-01-16
- FDA Inspection 1251230 - 2024-09-12
- FDA Inspection 1112559 - 2019-11-07
- FDA Inspection 976682 - 2016-06-27
- FDA Inspection 869531 - 2014-03-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.